Negative regulators of PARK7/DJ1 |
H2O2
|
Overoxidation |
Human brain |
[80,81] |
p53 |
Reduced expression |
mouse embryonic fibroblasts |
[91] |
BAG5 |
Decreased stability |
HEK293 human embryonic kidney |
[92] |
MMP-3 |
Proteomic fragmentation |
CATH.a mouse neuronal |
[93] |
LPS |
Reduced expression |
HT-29 human colonic adenocarcinoma |
[11] |
TNF-α |
Reduced expression |
HT-29 human colonic adenocarcinoma |
[11] |
TGF-β |
Reduced expression |
HT-29 human colonic adenocarcinoma |
[11] |
miR-128-3p |
Reduced expression |
Human hepatocellular carcinoma |
[94] |
miR-494 |
Reduced expression |
3T3-L1 mouse adipocytes and Neuro-2a neuroblastoma |
[96] |
miR-203 |
Reduced expression |
SW1990/DDP human pancreatic cancer cells |
[95] |
Positive regulators of PARK7/DJ1 |
STAT5A |
Increased expression |
human leukemic pre-B |
[97] |
SG2NA |
Protection from degradation |
Neuro2a neuroblastoma |
[99,100] |
IL-17 |
Increased expression |
HT-29 human colonic adenocarcinoma |
[11] |
H2O2
|
Increased expression |
HT-29 human colonic adenocarcinoma |
[11] |